Search

everythinglearnresearchcommunity

for

Search:↓

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Dutasteride and finasteride affect different cell types differently.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Androgens play a key role in hair growth and disorders like baldness and excessive hairiness.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Sebocytes play a key role in controlling androgen levels in human skin.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Finasteride safely lowers DHT levels without affecting testosterone.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.